Glatopa (Sandoz Inc)
Welcome to the PulseAid listing for the Glatopa drug offered from Sandoz Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | Glatiramer Acetate |
| SUBSTANCE NAME: | GLATIRAMER ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-06-18 |
| END MARKETING DATE: | 0000-00-00 |
Glatopa HUMAN PRESCRIPTION DRUG Details:
| Item Description | Glatopa from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2015-06-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0781-3234_c8eaa1ab-c679-47fc-a8d7-cb3280843df6 |
| PRODUCT NDC: | 0781-3234 |
| APPLICATION NUMBER: | ANDA090218 |
Other GLATIRAMER ACETATE Pharmaceutical Manufacturers / Labelers:
